Personal tools

Coexpression cluster:C2849: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C2849_Mast_plasma_splenic_migratory_Burkitt_CD14CD16_xeroderma |id=C2849 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C2849_Mast_plasma_splenic_migratory_Burkitt_CD14CD16_xeroderma
|full_id=C2849_Mast_plasma_splenic_migratory_Burkitt_CD14CD16_xeroderma
|id=C2849
|id=C2849
|ontology_enrichment_celltype=CL:0000738!9.95e-62!140;CL:0002031!1.85e-48!124;CL:0002087!9.14e-48!119;CL:0000988!4.42e-47!182;CL:0000037!1.46e-46!172;CL:0000566!1.46e-46!172;CL:0000766!9.40e-46!76;CL:0002032!1.26e-45!165;CL:0000837!1.26e-45!165;CL:0002057!1.19e-44!42;CL:0000860!9.48e-41!45;CL:0000557!1.05e-37!71;CL:0000839!9.37e-37!70;CL:0002009!9.18e-35!65;CL:0002194!1.38e-34!63;CL:0000576!1.38e-34!63;CL:0000040!1.38e-34!63;CL:0000559!1.38e-34!63;CL:0000763!2.45e-32!112;CL:0000049!2.45e-32!112;CL:0000945!2.37e-25!24;CL:0000826!2.37e-25!24;CL:0000236!2.17e-17!14;CL:0002393!4.98e-13!9;CL:0002397!4.98e-13!9;CL:0000838!5.10e-12!52;CL:0000542!1.20e-11!53;CL:0000051!1.20e-11!53;CL:0000134!5.20e-11!358;CL:0002320!2.36e-10!365;CL:0000990!9.32e-10!8;CL:0000080!6.11e-09!6;CL:0000094!9.12e-09!8;CL:0000219!1.78e-08!390;CL:0000081!5.13e-08!11;CL:0000451!1.17e-07!10;CL:0000048!7.22e-07!430
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002390!1.36e-44!102;UBERON:0003061!1.36e-44!102;UBERON:0002193!8.21e-42!112;UBERON:0002371!1.18e-31!80;UBERON:0001474!1.27e-29!86;UBERON:0002405!1.02e-25!115;UBERON:0004765!7.26e-23!101;UBERON:0001434!7.26e-23!101;UBERON:0003081!7.66e-14!216;UBERON:0002204!4.74e-11!167;UBERON:0000178!4.02e-10!15;UBERON:0000179!4.02e-10!15;UBERON:0000463!4.02e-10!15;UBERON:0002384!1.82e-09!375
}}
}}

Revision as of 14:29, 21 May 2012


Full id: C2849_Mast_plasma_splenic_migratory_Burkitt_CD14CD16_xeroderma



Phase1 CAGE Peaks

Hg19::chr6:155504411..155504418,+p16@TIAM2
Hg19::chr6:155504423..155504442,+p4@TIAM2
Hg19::chr6:155504446..155504462,+p5@TIAM2
Hg19::chr6:155504495..155504502,+p@chr6:155504495..155504502
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
leukocyte9.95e-62140
hematopoietic lineage restricted progenitor cell1.85e-48124
nongranular leukocyte9.14e-48119
hematopoietic cell4.42e-47182
hematopoietic stem cell1.46e-46172
angioblastic mesenchymal cell1.46e-46172
myeloid leukocyte9.40e-4676
hematopoietic oligopotent progenitor cell1.26e-45165
hematopoietic multipotent progenitor cell1.26e-45165
CD14-positive, CD16-negative classical monocyte1.19e-4442
classical monocyte9.48e-4145
granulocyte monocyte progenitor cell1.05e-3771
myeloid lineage restricted progenitor cell9.37e-3770
macrophage dendritic cell progenitor9.18e-3565
monopoietic cell1.38e-3463
monocyte1.38e-3463
monoblast1.38e-3463
promonocyte1.38e-3463
myeloid cell2.45e-32112
common myeloid progenitor2.45e-32112
lymphocyte of B lineage2.37e-2524
pro-B cell2.37e-2524
B cell2.17e-1714
intermediate monocyte4.98e-139
CD14-positive, CD16-positive monocyte4.98e-139
lymphoid lineage restricted progenitor cell5.10e-1252
lymphocyte1.20e-1153
common lymphoid progenitor1.20e-1153
mesenchymal cell5.20e-11358
connective tissue cell2.36e-10365
conventional dendritic cell9.32e-108
circulating cell6.11e-096
granulocyte9.12e-098
motile cell1.78e-08390
blood cell5.13e-0811
dendritic cell1.17e-0710
multi fate stem cell7.22e-07430
Uber Anatomy
Ontology termp-valuen
hematopoietic system1.36e-44102
blood island1.36e-44102
hemolymphoid system8.21e-42112
bone marrow1.18e-3180
bone element1.27e-2986
immune system1.02e-25115
skeletal element7.26e-23101
skeletal system7.26e-23101
lateral plate mesoderm7.66e-14216
musculoskeletal system4.74e-11167
blood4.02e-1015
haemolymphatic fluid4.02e-1015
organism substance4.02e-1015
connective tissue1.82e-09375


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.